MedTrace Logo

Safety and Tolerability of AZD5148 in Japanese Participants

NCT06639997 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-01-30

No results posted yet for this study

Summary

The purpose of this study is to measure safety, tolerability and PK of a single dose of AZD5148 administered via IV bolus or IM injection in healthy Japanese participants.

Conditions

  • Clostridioides Difficile Infection

Interventions

DRUG

AZD5148

Participants will receive AZD5148 as IM injection or IV bolus

DRUG

Placebo

Participants will receive matching doses of placebo as an IM injection or IV bolus

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-12-25
Completion
2025-12-25

Countries

  • Japan

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06639997 on ClinicalTrials.gov